Reaction profile

The FDA adverse-event record for hemiplegia

Name: Hemiplegia - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

22 FDA reports name hemiplegia, a lower-volume reaction in the CVM extract (VeDDRA 693). Plate stamps and neighbourhood peers follow.

#2127 of 2,481
by report volume (all reactions): 22
reports citing this reaction: 27.3%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Hemiplegia has 22 reports now versus 21 in that prior snapshot: 1 more (4.8%).

Report change: +1
Death-coded reports: +1
Death-coded share: +3.5 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Hemiplegia changes

FDA AER · VeDDRA plate

Code 693 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 22 reports
DEATH-HOT 27.3%
LOWER-Q #2127/2481
PHOTO-FINISH Adenocarcinoma NOS
SPECIES-DOG Dog · 18
DRUG-LEAD Bedinvetmab · 3
DESK-WIDE 20 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Adenocarcinoma NOS (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Hemiplegia

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Hemiplegia

Hemiplegia: high death-coded share in the FDA AER plate

Signature read: 22 reports place Hemiplegia in the lower third of FDA AER volume (#2127 of 2,481). Report volume is lower-third scale: 22 named reports in the openFDA extract. Death-coded share is upper-third: 6 of 22 reports (27.3% of named reports). Nearest volume peer: Adenocarcinoma NOS (±0 reports). Lead species Dog (18). Lead co-reported drug Bedinvetmab (3).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 18

Cat 4

Breeds Most Affected

Domestic Shorthair 2

Retriever - Golden 2

Spaniel - Clumber 1

Akita 1

Domestic Mediumhair 1

Chihuahua 1

Spitz - German Pomeranian 1

Ridgeback - Rhodesian 1

Spaniel - Cocker American 1

Terrier - Boston 1

Associated Drugs

Bedinvetmab 3

Spinosad 2

Cefovecin 2

Maropitant Citrate 2

Enrofloxacin 2

Fluralaner Chew Tablets 2

Milbemycin Oxime + Praziquantel 2

Imidacloprid + Permethrin + N-Methylpyrolidone 1

Dexmedetomidine Hydrochloride 1

Robenacoxib 1

Buprenorphine 1

Atropine 1

Mirtazapine 1

Toceranib Phosphate 1

Carprofen 1

Milbemycin Oxime + Spinosad 1

Praziquantel 1

Triamcinolone Acetonide 1

Moxidectin 1

Acetylsalicylic Acid 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Hemiplegia (#2127 of 2,481 by report volume); death-coded 27.3%. PlainBreed reaction plate · report volume stamp 22 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →